A 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide DMF (Drug Master File) is a document detailing the whole manufacturing process of 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide active pharmaceutical ingredient (API) in detail. Different forms of 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide DMFs exist exist since differing nations have different regulations, such as 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide DMF submitted to regulatory agencies in the US is known as a USDMF. 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide USDMF includes data on 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide suppliers with USDMF on PharmaCompass.